KIVEXA ישראל - אנגלית - Ministry of Health

kivexa

glaxo smith kline (israel) ltd - abacavir as sulfate; lamivudine - film coated tablets - abacavir as sulfate 600 mg; lamivudine 300 mg - nucleoside and nucleotide reverse transcriptase inhibitors - kivexa is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults, adolescents and children weighing at least 25 kg.

KIVEXA ישראל - אנגלית - Ministry of Health

kivexa

glaxo smith kline (israel) ltd - abacavir as sulfate; lamivudine - film coated tablets - abacavir as sulfate 600 mg; lamivudine 300 mg - kivexa is a fixed-dose combination of two nucleoside analogues (abacavir and lamivudine). it is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.28/10/2018 עדכון התוויה: kivexa is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and, adolescents s of and children weighing at least 25 kg.שינוי משטר מינון:adults, adolescents and children weighing at least 25 kg:the recommended dose of kivexa is one tablet once daily.children under 25 kg: kivexa should not be administered children who weigh less than 25 kg because it is a fixed dose tablet that cannot be dose reduced.paediatric population: the safety and efficacy of kivexa in children weighing less than 25 kg has not been established. currently available data are described in section 4.8, 5.1 and 5.2 but no recommendation on posology can be made.

RETROVIR Capsule 250mg Milligram אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

retrovir capsule 250mg milligram

glaxosmithkline (ireland) limited - zidovudine - capsule - 250mg milligram